Literature DB >> 16133413

Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum.

L Cock De1, V Hutse, R Vranckx.   

Abstract

Reported here are the results of a study designed to determine the correlation between hepatitis C virus (HCV) RNA positivity in serum and the detection of antibodies against HCV in oral fluid by testing paired serum/oral fluid samples. For the 85 serum samples found positive for antibodies against HCV, using a screening assay and a confirmation assay, 70 of the corresponding oral fluid samples tested positive for HCV antibodies using a previously modified screening assay. For 52 of the 59 serum samples found positive for HCV RNA, the corresponding oral fluid samples also tested seropositive for HCV, while 18 of the 26 serum samples that were negative for HCV RNA had corresponding oral fluid samples that tested seropositive for HCV. For the control group of 54 serum samples that were negative for HCV antibodies, all of the corresponding oral fluid samples were also negative for HCV antibodies, while 53 of the serum samples tested negative for HCV RNA. These results suggest that HCV antibody detection in oral fluid has a slightly higher sensitivity when used to test patients whose serum samples are positive for HCV RNA (chi-square test, p=0.035; Mid-P exact, p=0.049).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133413     DOI: 10.1007/s10096-005-1369-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Detection of HCV antibodies in oral fluid.

Authors:  L De Cock; V Hutse; E Verhaegen; S Quoilin; H Vandenberghe; R Vranckx
Journal:  J Virol Methods       Date:  2004-12-15       Impact factor: 2.014

2.  HCV antibodies in saliva and urine.

Authors:  S Elsana; E Sikuler; A Yaari; Y Shemer-Avni; M Abu-Shakra; D Buskila; P Katzman; L Naggan; M Margalith
Journal:  J Med Virol       Date:  1998-05       Impact factor: 2.327

3.  The use of oral fluid for hepatitis C antibody screening.

Authors:  K E Sherman; R L Creager; J O'Brien; S Sargent; S Piacentini; T Thieme
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

Review 4.  The use of saliva for viral diagnosis and screening.

Authors:  P P Mortimer; J V Parry
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

5.  Salivary HCV-antibodies; a follow-up cohort study of liver disease patients.

Authors:  S Elsana; E Sikuler; A Yaari; Y Shemer-Avni; M Margalith
Journal:  Clin Lab       Date:  2001       Impact factor: 1.138

6.  Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group.

Authors:  J Saldanha; A Heath; N Lelie; G Pisani; M Nübling; M Yu
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

7.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

8.  Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication.

Authors:  S O Cameron; K S Wilson; T Good; J McMenamin; B McCarron; A Pithie; R Fox
Journal:  J Viral Hepat       Date:  1999-03       Impact factor: 3.728

9.  Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies.

Authors:  P Y Bello; C Pasquier; P Gourney; J Puel; J Izopet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

10.  Sensitive assays for viral antibodies in saliva: an alternative to tests on serum.

Authors:  J V Parry; K R Perry; P P Mortimer
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

View more
  2 in total

1.  Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display.

Authors:  Fang Chen; Yinglan Zhao; Min Liu; Dongqing Li; Hongyan Wu; Haidan Chen; Yongzhe Zhu; Fengling Luo; Jin Zhong; Yidan Zhou; Zhongtian Qi; Xiao-Lian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

2.  CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.

Authors:  Fang Chen; Yilan Hu; Dongqing Li; Haidan Chen; Xiao-Lian Zhang
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.